| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-06-12 | 8-K | Form 8-K, Item 5.07 |
| 2026-06-09 | Press release | Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference |
| 2026-05-07 | Press release | Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update |
| 2026-05-05 | Deck | Investor presentation · May 2026 |
| 2026-05-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-05 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-21 | Proxy | Definitive proxy statement |
| 2026-04-20 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-23 | 8-K | Form 8-K, Item 5.02 |
| 2026-03-03 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-28 | Press release | Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in L |
| 2026-02-25 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-25 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-14 | Press release | Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs |
| 2026-01-10 | Deck | J.P. Morgan Healthcare Conference 2026 Oncology and Immunology Portfolio |
| 2025-12-18 | 8-K | Form 8-K, Item 1.01 |
| 2025-12-12 | 8-K | Form 8-K, Item 8.01 |
| 2025-11-03 | 8-K | Form 8-K, Item 8.01 |
| 2025-10-28 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-28 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-14 | 8-K | Form 8-K, Item 8.01 |
| 2025-10-06 | 8-K | Form 8-K, Item 8.01 |
| 2025-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-06-12 | 8-K | Form 8-K, Item 5.07 |
| 2025-06-02 | 8-K | Form 8-K, Item 7.01 |
| 2025-05-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-05-06 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-04-22 | Proxy | Definitive proxy statement |
| 2025-02-25 | 8-K | Form 8-K, Item 2.02 results |
| 2025-02-25 | 10-K | Annual report on Form 10-K, FY24 |
| 2025-02-19 | 8-K | Form 8-K, Item 8.01 |
| 2025-02-18 | 8-K | Form 8-K, Item 2.02 results |
| 2025-02-06 | 8-K | Form 8-K, Item 5.02 |
| 2025-01-21 | 8-K | Form 8-K, Item 5.02 |
| 2024-11-06 | 8-K | Form 8-K, Item 2.02 results |
| 2024-11-06 | 10-Q | Form 10-Q for the quarter ended Sep 30 |